Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator

OBJECTIVE: Impaired cardiac adrenergic activity has been demonstrated in heart failure (HF) and in diabetes mellitus (DM). [(123)I]I-metaiodobenzylguanidine (MIBG) enables assessment of the cardiac adrenergic nervous system. Tomographic imaging of the heart is expected to be superior to planar imagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Teresińska, Anna, Woźniak, Olgierd, Maciąg, Aleksander, Wnuk, Jacek, Jezierski, Jarosław, Fronczak, Aneta, Biernacka, Elżbieta Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285320/
https://www.ncbi.nlm.nih.gov/pubmed/34023989
http://dx.doi.org/10.1007/s12149-021-01628-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285320/
https://www.ncbi.nlm.nih.gov/pubmed/34023989
http://dx.doi.org/10.1007/s12149-021-01628-1

Ejemplares similares